2025-07-09
From July 5 to 7, 2025, the 2025 (42nd) National Pharmaceutical Industry Information Annual Conference was held in Beijing. During the conference, a series of rankings including the "2025 Top 100 Chinese Pharmaceutical Industry Enterprises" were prominently released. Baiyang Pharmaceutical (301015.SZ), after being listed in the "China's Emerging Innovative Pharmaceutical Forces" in 2024, was once again honored as the "Best Industrial Enterprise in Pharmaceutical R&D Product Lines in China 2025" due to its outstanding performance in product layout, innovation system, and commercialization platform construction.
+
2025-05-16
On May 16, 2025, Qingdao Baiyang Pharmaceutical Co., Ltd., a subsidiary of Baiyang Pharmaceutical (301015.SZ), held the relocation ceremony for the Phase III construction project. Zhu Xiaowei, Director of Baiyang Pharmaceutical Group, Vice President of Baiyang Pharmaceutical, and Chairman of Baiyang Pharmaceutical; Hao Yu, Vice President of Park Operations of Baiyang Pharmaceutical Group; Zheng Aiju, General Manager of Qingdao Baiyang Pharmaceutical; along with other leaders, guests, and colleagues from Qingdao Baiyang Pharmaceutical attended the event to witness this important moment together.
+
2025-03-03
Recently, the star product "Fuzheng Huayu Tablets" from Shanghai Huanghai Pharmaceutical Co., Ltd., a subsidiary of Shanghai Baheal Pharma Co., Ltd., has officially received a product license from Canada’s Natural and Non-Prescription Health Products Directorate (NNHPD) under Health Canada. This achievement underscores the company’s breakthrough in the inheritance and innovation of traditional Chinese medicine (TCM) and is poised to accelerate the global expansion of Fuzheng Huayu.
+
2025-01-04
On December 31, 2024, the Shuanghai brand Danshen tablets (180 tablets) produced by Shanghai Huanghai Pharmaceutical, a subsidiary of Shanghai Baiyang Pharmaceutical, passed strict review and fierce competition, and won the bid for centralized procurement of the National traditional Chinese patent medicines and simple preparations Purchasing Alliance led by Hubei Province, which means that more patients can enjoy this high-quality medical resource at a more affordable price, which is a solid step on the road of fulfilling our social responsibility.
+
